Related Experiment Video
Updated: Sep 8, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Effect of Mycobacterium w on IL-6 and Oxygen Requirement in COVID-19
Shailaja Behera1, Mukesh K Gupta1, Hardik Dudhatra2
1Consultant; Apex Super Specialty Hospital & Postgraduate Institute, Varanasi, Uttar Pradesh, India.
Abstract:
The efficacy and safety of heat-killed Mycobacterium w (Mw) in severe COVID-19 were evaluated. Twenty-five hospitalized patients (mean age, 52.9 ± 13.1 years) with severe COVID-19 and having multiple comorbidities were intradermally injected with 0.3 mL of Mw daily for three consecutive days. Changes in leukocyte and platelet counts; C-reactive protein (CRP), interleukin-6 (IL-6), serum creatinine, and liver enzyme levels; and oxygen saturation were compared before and after treatment. An ordinal scale assessed the clinical response. There were significant improvements in the IL-6 level and oxygen saturation following treatment (p < 0.001). There were marked improvements in the platelet count, CRP level, serum aspartate transaminase level, and ordinal scale score. Eighty percent of patients who were on oxygen support were successfully shifted to room air within 5.6 days of treatment and discharged. No systemic adverse events were noted. Thus, Mw treatment could be a promising therapeutic modality in severe COVID-19.
Insights
Heat-killed Mycobacterium w (Mw) shows promise for severe COVID-19. This treatment improved oxygen saturation and IL-6 levels, with 80% of patients discharged after successful oxygen weaning.
Area of Science:
- Immunology
- Infectious Diseases
- Pulmonology
Background:
- Severe COVID-19 presents significant challenges, often requiring intensive care.
- Comorbidities complicate COVID-19 management and patient outcomes.
- Exploring novel therapeutic agents is crucial for improving severe COVID-19 treatment.
Purpose of the Study:
- To evaluate the efficacy and safety of heat-killed Mycobacterium w (Mw) in patients with severe COVID-19.
- To assess the impact of Mw treatment on key clinical and laboratory parameters.
Main Methods:
- A study involving 25 hospitalized patients with severe COVID-19 and comorbidities.
- Intradermal injection of 0.3 mL of heat-killed Mycobacterium w (Mw) daily for three consecutive days.
- Comparison of clinical and laboratory markers (leukocyte and platelet counts, CRP, IL-6, liver enzymes, oxygen saturation) before and after Mw treatment.
Main Results:
- Significant improvements observed in interleukin-6 (IL-6) levels and oxygen saturation (p < 0.001).
- Marked enhancements in platelet count, C-reactive protein (CRP) levels, liver enzymes, and clinical response scores.
- Eighty percent of patients on oxygen support were weaned to room air within 5.6 days, leading to discharge.
Conclusions:
- Heat-killed Mycobacterium w (Mw) demonstrates potential as a safe and effective therapeutic option for severe COVID-19.
- Mw treatment may contribute to faster recovery and reduced hospital stay in severe COVID-19 patients.
- Further research into Mw as a COVID-19 therapeutic modality is warranted.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia II: Pathophysiology
Oxygen Requirements and Growth Patterns
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

